New drug ALT-BB4 put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested the safety and tolerance of a new drug called ALT-BB4 in 290 healthy adults. The main goal was to see how many people had allergic reactions or other side effects at the injection site. Since it was a Phase 1 trial in healthy volunteers, there was no…
Phase: PHASE1 • Sponsor: Alteogen, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC